Efficacy of immunotherapy for melanoma brain metastases in patients with concurrent corticosteroid exposure

AIM: Immune checkpoint inhibitor (ICI) efficacy is undefined for melanoma brain metastases (MBM) with concurrent corticosteroid exposure. MATERIALS & METHODS: We retrospectively evaluated patients with untreated MBM who received corticosteroids (≥1.5 mg dexamethasone equivalent) within 30 days o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tringale, Kathryn R, Reiner, Anne S, Sehgal, Ryka R, Panageas, Katherine, Betof Warner, Allison S, Postow, Michael A, Moss, Nelson S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996406/
https://www.ncbi.nlm.nih.gov/pubmed/36802833
http://dx.doi.org/10.2217/cns-2022-0014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996406/
https://www.ncbi.nlm.nih.gov/pubmed/36802833
http://dx.doi.org/10.2217/cns-2022-0014

Ejemplares similares